CLINICAL OBSERVATIONS ON THE EFFICACY OF METARAMINOL IN THE TREATMENT OF SHOCK.
D002561:Cerebrovascular Disorders; D006471:Gastrointestinal Hemorrhage; D006470:Hemorrhage; D006801:Humans; D006973:Hypertension; D006974:Hypertension, Malignant; D008103:Liver Cirrhosis; D008581:Meningitis; D008680:Metaraminol; D009203:Myocardial Infarction; D009638:Norepinephrine; D010439:Peptic Ulcer Perforation; D010538:Peritonitis; D011014:Pneumonia; D011704:Pyelonephritis; D012214:Rheumatic Heart Disease; D012769:Shock
D008680:Metaraminol; D009638:Norepinephrine
CEREBROVASCULAR DISORDERS; HEMORRHAGE, GASTROINTESTINAL; HYPERTENSION, MALIGNANT; LIVER CIRRHOSIS; MENINGITIS; METARAMINOL; MYOCARDIAL INFARCT; NOREPINEPHRINE; PEPTIC ULCER PERFORATION; PERITONITIS; PNEUMONIA; PYELONEPHRITIS; RHEUMATIC HEART DISEASE; SHOCK